While the Buy rating reaffirms confidence in Tenet Healthcare's fundamentals and potential growth, the reduction in price target suggests that there may be factors that could limit the stock's upside in the short term. This could lead to a neutral short-term impact as the market digests both the continued endorsement and the lowered expectations.